Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-26-000057
Filing Date
2026-05-29
Accepted
2026-05-29 14:09:46
Documents
62
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20260331.htm   iXBRL 10-Q 633921
2 EX-31.1 exicureexhibit311-03_31x261.htm EX-31.1 7815
3 EX-31.2 exicureexhibit312-03_31x26.htm EX-31.2 7812
4 EX-32.1 exicureexhibit321-03_31x26.htm EX-32.1 8466
  Complete submission text file 0001698530-26-000057.txt   4285805

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20260331.xsd EX-101.SCH 37831
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20260331_cal.xml EX-101.CAL 53160
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20260331_def.xml EX-101.DEF 129637
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20260331_lab.xml EX-101.LAB 483929
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20260331_pre.xml EX-101.PRE 319210
66 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20260331_htm.xml XML 414573
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 261042102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)